Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kuros Bioscience Ord New (OP:CSBTF)

32.00 +0.09 (+0.27%)
Streaming Delayed Price Updated: 9:35 AM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 250
Open 32.00
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 31.91
Today's Range 32.00 - 32.00
52wk Range 19.44 - 42.81
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Kuros Biosciences USA, Inc. Announces an Exclusive Strategic Agreement with the Medtronic Spinal Division
Via ACCESSWIRE
News headline image
Kuros Biosciences Expands into Extremities Markets
Via ACCESSWIRE

Performance

YTD
-7.6%
-7.6%
1 Month
-7.6%
-7.6%
3 Month
-16.1%
-16.1%
6 Month
-7.9%
-7.9%
1 Year
+38.5%
+38.5%

More News

Read More
News headline image
Kuros Reports 149% Increase in Direct MagnetOs Sales and Exceeds Cash Flow Breakeven in the First Nine Months of 2024
Via ACCESSWIRE
News headline image
Kuros Biosciences Reports First Half of 2024 Results
Via ACCESSWIRE
News headline image
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft
Via ACCESSWIRE
News headline image
Kuros Reports Corporate Highlights as of Q1 2024 Including Increase in Direct MagnetOsTM Sales
Via ACCESSWIRE
News headline image
Annual General Meeting of Kuros Biosciences Approves All Resolutions
Via ACCESSWIRE
News headline image
Kuros Reports 163% Growth in Direct MagnetOs Sales and 153% Increase in Total Medical Device Sales for the Full Year 2023
Via ACCESSWIRE
News headline image
Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update
Via ACCESSWIRE
News headline image
Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference
Via ACCESSWIRE
News headline image
Kuros Biosciences Receives US FDA 510K Clearance for MagnetOs Granules for Interbody Use and Regulatory Clearance of MagnetOs Granules and MagnetOs Putty in New Zealand
Via ACCESSWIRE
News headline image
Kuros Biosciences Announces Three Advancements Related to its MagnetOsTM Portfolio Including Impressive Fusion Data from MAXA Prospective Randomized Clinical Trial and Two 510(k) Clearances from FDA
Via ACCESSWIRE
News headline image
Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA
Via ACCESSWIRE
News headline image
Kuros Biosciences Receives FDA Clearance for Use of MagnetOs in Interbody Spinal Cages
Via ACCESSWIRE
News headline image
Kuros Reports a 150% Increase in Direct MagnetOs Sales in the First Nine Months of 2023 and Announces Changes Within the Executive Management
Via ACCESSWIRE

Frequently Asked Questions

Is Kuros Bioscience Ord New publicly traded?
Yes, Kuros Bioscience Ord New is publicly traded.
What exchange does Kuros Bioscience Ord New trade on?
Kuros Bioscience Ord New trades on the OTC Traded
What is the ticker symbol for Kuros Bioscience Ord New?
The ticker symbol for Kuros Bioscience Ord New is CSBTF on the OTC Traded
What is the current price of Kuros Bioscience Ord New?
The current price of Kuros Bioscience Ord New is 32.00
When was Kuros Bioscience Ord New last traded?
The last trade of Kuros Bioscience Ord New was at 02/11/26 09:35 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.